- Report
- March 2023
- 132 Pages
Global
From €916EUR$950USD£783GBP
- Report
- February 2022
- 142 Pages
Global
From €4338EUR$4,500USD£3,710GBP
- Report
- July 2020
- 229 Pages
Global
From €5948EUR$6,169USD£5,087GBP
- Report
- October 2023
- 140 Pages
Global
From €5524EUR$5,730USD£4,725GBP
- Report
- February 2024
- 140 Pages
Vietnam
From €3566EUR$3,699USD£3,050GBP
- Book
- July 2022
- 880 Pages
The Embolic Protection Device (EPD) market is a subset of the Cardiovascular Devices market. EPDs are medical devices used to capture and remove debris from the bloodstream during endovascular procedures. These devices are designed to reduce the risk of stroke and other embolic events. EPDs are typically used in procedures such as carotid artery stenting, transcatheter aortic valve replacement, and atrial septal defect closure.
EPDs are typically composed of a filter, a delivery system, and a retrieval system. The filter is placed in the bloodstream to capture debris, while the delivery and retrieval systems are used to place and remove the filter. The filter is typically made of a mesh material, such as nitinol, and is designed to capture debris without blocking blood flow.
The EPD market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Abbott, Boston Scientific, Medtronic, and Terumo. Show Less Read more